Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice

Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice

Muhammed A Saad,1,2 Noha M Eissa,2 Mohammed A Ahmed,3 Aliaa N ElMeshad,3,4 Götz Laible,5– 7 Ahmed S Attia,8 Medhat A Al-Ghobashy,9,10 Rania M Abdelsalam,1,2 Muhammad Y Al-Shorbagy1,11 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2School of Pharmacy...

Full description

Bibliographic Details
Main Authors: Saad MA, Eissa NM, Ahmed MA, ElMeshad AN, Laible G, Attia AS, Al-Ghobashy MA, Abdelsalam RM, Al-Shorbagy MY
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:International Journal of Nanomedicine
Subjects:
multiple sclerosis
experimental autoimmune encephalomyelitis
nanoparticle
rituximab
recombinant human myelin basic protein
Online Access:https://www.dovepress.com/nanoformulated-recombinant-human-myelin-basic-protein-and-rituximab-mo-peer-reviewed-fulltext-article-IJN

Internet

https://www.dovepress.com/nanoformulated-recombinant-human-myelin-basic-protein-and-rituximab-mo-peer-reviewed-fulltext-article-IJN

Similar Items